Feed/Companies/Kailera

Kailera

As of 14 Oct 2026, Kailera has raised $600M across 1 verified round on record; latest: $600 million Series B led by Bain Capital Private Equity, announced 14 Oct 2025.

BUILT ON

Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people living with obesity

kailera.comLinkedInWaltham, Mass.Public company

LATEST ROUND

Series B

$600M · 2025-10-14

RAISED ON RECORD · USD

$600M

across 1 verified round

INVESTORS

1 lead

SOURCES

from 2 publishers

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series B

$600M · 2025-10-14

[ HISTORY ]

led by Bain Capital Private Equity

Round	Amount	Announced	Lead	Buzz
Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$600M	2025-10-14	Bain Capital Private Equity	No recent discussion
2 sources [ VERIFIED · CORRECTED ] read against 2 sources The sources agree.

Kailera

Company

Rounds

Sources

Profile

Investors

Kailera

Rounds

Profile

Sources

Series B$600M2025-10-142 sources

Investors

Series B$600M2025-10-1414 investors